
Lazertinib - Wikipedia
Lazertinib, sold under the brand names Lazcluze and Leclaza among others, is an anti-cancer medication used for the treatment of …
Lazertinib Uses, Side Effects & Warnings - Drugs.com
Sep 21, 2026 · What is lazertinib? Lazertinib is used in combination with amivantamab to treat adults with certain type of non-small …
LAZCLUZE® (lazertinib) - Janssen Science
This site provides access to current scientific information about LAZCLUZE® (lazertinib)
Lazertinib (oral route) - Side effects & dosage - Mayo Clinic
Medicines used to treat cancer are very strong and can have many side effects. Before using this medicine, make sure you …
Lazcluze (Lazertinib) - Uses, Side Effects, and More
Oct 29, 2026 · Lazcluze (lazertinib) is commonly used to treat certain types of non-small cell lung cancer (NSCLC). Lazcluze may …
Lazertinib (Lazcluze™) - OncoLink
Aug 27, 2026 · Lazertinib is usually given in combination with another medication called amivantamab. Lazertinib is a kinase inhibitor …
Lazertinib is a kinase inhibitor of epidermal growth factor receptor (EGFR) that inhibits EGFR exon 19 deletions and exon 21 L858R …
Lazcluze: Uses, Dosage, Side Effects, Warnings - Drugs.com
Jul 30, 2026 · Lazcluze (lazertinib) is a first-line treatment for certain types of EGFR-mutated non-small cell lung cancer (NSCLC) in …
Lazertinib: First Approval - PMC
Lazertinib (LECLAZA®) is an oral, third-generation, epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) being …
LAZCLUZE - Dosage and Administration - Janssen Science
2 days ago · A summary of available information regarding the dosage and administration of LAZCLUZE® (lazertinib).